Regular aspirin use tied to lower ovarian cancer risk

02/6/2014 | HealthDay News

An analysis of data from 12 studies involving nearly 20,000 women found that taking aspirin daily was tied to a 20% reduced risk for developing ovarian cancer, compared with using the drug less than weekly. The study, published in the Journal of the National Cancer Institute, found no link between acetaminophen intake and ovarian cancer risk. An association between non-aspirin nonsteroidal anti-inflammatory drugs such as naproxen and reduced ovarian cancer risk was not found to be significant.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX